Atossa Therapeutics, Inc. (ATOS)

NASDAQ: ATOS · Real-Time Price · USD

2.170

-0.060 (-2.69%)

At close: Oct 30, 2026, 4:00 PM EDT

2.279

+0.109 (5.04%)

After-hours: Oct 30, 2026, 7:30 PM EDT

Atossa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26.09	41.3	71.08	88.46	110.89	136.38
Cash & Short-Term Investments	26.09	41.3	71.08	88.46	110.89	136.38
Cash Growth	-54.90%	-41.90%	-19.64%	-20.23%	-18.69%	244.79%
Other Receivables	-	-	-	-	0.74	1.07
Receivables	-	-	-	-	0.74	1.07
Inventory	3.01	3.08	2.1	1.49	5.25	-
Prepaid Expenses	0.57	0.59	0.7	1.3	1.21	2.49
Restricted Cash	0.11	0.11	0.11	0.11	0.11	0.11
Other Current Assets	1.23	0.54	0.47	0.87	-	1.19
Total Current Assets	31.01	45.62	74.46	92.22	118.2	141.24
Long-Term Investments	-	-	-	1.71	4.7	-
Other Long-Term Assets	1.27	1.99	1.99	2.32	0.64	0.02
Total Assets	32.28	47.61	76.44	96.25	123.53	141.26

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.98	4.29	0.68	0.81	2.97	1.72
Accrued Expenses	2.35	2.87	2.78	2.63	2.58	1.39
Other Current Liabilities	1.12	1.1	1.51	1.8	0.02	0.02
Total Current Liabilities	5.45	8.26	4.97	5.24	5.57	3.13
Total Liabilities	5.45	8.26	4.97	5.24	5.57	3.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1.8	1.55	1.55	22.79	22.79	22.79
Additional Paid-In Capital	291.15	285.84	283.19	255.99	251.37	244
Retained Earnings	-264.64	-246.56	-211.79	-186.29	-156.19	-129.23
Treasury Stock	-1.48	-1.48	-1.48	-1.48	-	-
Total Common Equity	26.83	39.35	71.48	91.02	117.96	137.55
Shareholders' Equity	26.83	39.35	71.48	91.02	117.96	138.14
Total Liabilities & Equity	32.28	47.61	76.44	96.25	123.53	141.26

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	26.09	41.3	71.08	88.46	110.89	136.38
Net Cash Growth	-54.90%	-41.90%	-19.64%	-20.23%	-18.69%	244.94%
Net Cash Per Share	3.01	4.80	8.47	10.52	13.14	17.49
Filing Date Shares Outstanding	9.98	8.61	8.61	8.35	8.44	8.44
Total Common Shares Outstanding	9.98	8.61	8.61	8.35	8.44	8.44
Working Capital	25.56	37.36	69.49	86.98	112.63	138.11
Book Value Per Share	2.69	4.57	8.30	10.90	13.97	16.29
Tangible Book Value	26.83	39.35	71.48	91.02	117.96	137.55
Tangible Book Value Per Share	2.69	4.57	8.30	10.90	13.97	16.29

SEC Filings: 10-K · 10-Q